Novo Nordisk has released the results of its phase II trial of ziltivekimab, 'Rescue'. The drug, which is taken monthly, attained its primary goal of reducing inflammatory biomarkers associated with atherosclerosis (hardened arteries, -ed.) in people with advanced chronic kidney disease.
The press release written by Novo Nordisk states that the data was released at the American College of Cardiology's 70th annual conference (this year, a virtual conference) and published in the Lancet.
Already a subscriber? Log in.
Read the whole article
Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers.
Start a free company trial todayMore from MedWatch
Former Ambu CEO's equity investments end in USD 2m losses
Juan Jose Gonzalez, who was the CEO of medtech firm Ambu until very recently, has lost just over DKK 16m (USD 2.3m) before taxes on his share purchases.
Jesper Høiland retires as chief commercial officer of Ascendis Pharma
Former executive vice president of Novo Nordisk, US, Jesper Høiland has decided to step down from his role as global chief commercial officer at Ascendis Pharma.
ALK finds replacement for long-time North America lead
Jorge Alderete, ALK’s president in North America, is leaving the firm after 23 years. He will be replaced by Hans Lindeberg, ALK’s current head of the Nordic region.
Monkeypox vaccine attracts interest for Bavarian as virus spreads
Bavarian, which signed a supply contract with an unnamed European country last week, reports it is in dialog with several countries, some yet to be affected, concerning the firm’s monkeypox vaccine.
Almirall announces Danish launch of MC2 Therapeutics-developed psoriasis cream
Almirall is launching psoriasis cream Wynzora in Denmark. The treatment has been inlicensed from Danish firm MC2 Therapeutics, where the CEO says ”it is a special feeling” to see Wynzora launched in its home country.
Director for innovative pre-clinical testing unit 
Production Director 
Clinical Project Manager 
Cell Culture Scientist/Senior Scientist 
Project Manager & Scrum Master 
Procurement Manager, Direct Materials 
Nordic Medical Affairs Manager 
IRT Manager, Clinical Drug Supply 
Key Account Manager, Europe and Asia 
(Senior) Drug Substance Specialist 
Strategic Procurement Manager, Direct Spend (Category Manager) 
KLIFO is looking for a Clinical Supply Manager for our Glostrup office 
Director of Toxicology 
System Sales Development Consultant - Investment Projects, Merck Millipore 
2 Sales Representatives and Product Specialists 
CMO Operations Specialist - screening & selection of CMO/CDMO’s